Wet Macular Degeneration
Showing 26 - 46 of 46
Wet Macular Degeneration, Age-related Macular Degeneration, Diabetic Macular Edema Trial in Philadelphia (Dorzolamide-timolol)
Completed
- Wet Macular Degeneration
- +3 more
-
Philadelphia, PennsylvaniaWills Eye Hospital / Mid Atlantic Retina
Dec 1, 2019
Aflibercept in roUtine Clinical Practice in patientS With Wet
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Italy(unnamed)
Jul 28, 2019
Wet Macular Degeneration, Cataract Extraction Trial in Thessaloníki (Ranibizumab)
Unknown status
- Wet Macular Degeneration
- Cataract Extraction
-
Thessaloníki, Kalamaria, GreeceOphthalmica Eye Institute
May 8, 2019
Intravitreal Aflibercept and to Describe Follow-up as Well as
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Canada(unnamed)
Feb 14, 2019
Wet Macular Degeneration Trial in Japan (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Ichinomiya, Aichi, Japan
- +40 more
Dec 20, 2018
Wet Macular Degeneration Trial in China (Triamcinolone Acetonide, Ranibizumab)
Unknown status
- Wet Macular Degeneration
- Triamcinolone Acetonide
- Ranibizumab
-
Beijing, Beijing, China
- +6 more
Nov 29, 2018
Wet Macular Degeneration Trial in Barcelona (0.5mg aflibercept)
Completed
- Wet Macular Degeneration
- 0.5mg aflibercept
-
Barcelona, SpainBarcelona Macula Foundation
Nov 21, 2018
Outcomes in Patients Treated With AflIbercept in Real-life
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Lund, SwedenMany locations
Oct 26, 2018
Real Life of Aflibercept in France in Patients Refractory to
Completed
- Wet Macular Degeneration
- Aflibercept (EYLEA, BAY-86-5321)
-
Multiple Locations, France(unnamed)
Jun 29, 2018
Wet Macular Degeneration Trial in Seoul (Lucentis)
Completed
- Wet Macular Degeneration
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 17, 2018
Wet Macular Degeneration Trial in Hamilton (Ranibizumab, OZURDEX)
Completed
- Wet Macular Degeneration
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton Regional Eye Centre
Apr 5, 2018
Caregiver Burden of Wet Age-related Macular Degeneration in
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Many Locations, Japan(unnamed)
Aug 21, 2017
Wet Macular Degeneration, Macular Degeneration, Retinal Pigment Epithelial Detachment Trial in San Francisco, Lexington,
Terminated
- Wet Macular Degeneration
- +2 more
-
San Francisco, California
- +2 more
Mar 28, 2016
(NP/NA) in Wet Age-related Macular Degeneration (wAMD) Germany
Completed
- Wet Macular Degeneration
- Anti-VEGF injections
-
Many Locations, Germany(unnamed)
Sep 11, 2015
Wet Macular Degeneration Trial in Brescia (Ketorolac + Ranibizumab, Ranibizumab)
Completed
- Wet Macular Degeneration
- Ketorolac + Ranibizumab
- Ranibizumab
-
Brescia, BS, ItalySpedali Civili di Brescia
Feb 8, 2014
Age-Related Macular Degeneration, Wet Macular Degeneration, Macular Degeneration Trial in Manchester (IRay)
Unknown status
- Age-Related Macular Degeneration
- +4 more
- IRay
-
Manchester, United KingdomManchester Royal Eye Hospital
Apr 24, 2013
Macular Choroidal Neovascularization in a Chinese Population
Completed
- Geographic Atrophy
- +2 more
- Follow-up observation
-
Shanghai, Baoshan District, ChinaYouyi Street
Aug 14, 2012
Age-related Macular Degeneration, Pigment Epithelial Detachment, Neovascular Macular Degeneration Trial in San Francisco
Completed
- Age-related Macular Degeneration
- +3 more
-
San Francisco, CaliforniaPacific Eye Associates
Apr 10, 2012
Wet Macular Degeneration Trial in Toronto (Ranibizumab, Triamcinolone Acetonide)
Unknown status
- Wet Macular Degeneration
- Ranibizumab
- Triamcinolone Acetonide
-
Toronto, Ontario, CanadaUniversity Health Network-Toronto Western Hospital
Feb 8, 2011